Skip to main content
Livermore
Livermore
ZHEN

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
887,650
Value
$37.9M
% of portfolio
0.8%
Quarters held
22
Since Q1 2021
Holdings of BSX by Bellevue Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026887,650$37.9M0.8%−579,244−39.5%ReducedHolders
Q1 20261,466,894$92.0M2.2%−92,712−5.9%ReducedHolders
Q4 20251,559,606$148.7M2.8%−100,243−6.0%ReducedHolders
Q3 20251,659,849$162.1M3.4%−105,345−6.0%ReducedHolders
Q2 20251,765,194$189.6M4.2%−185,826−9.5%ReducedHolders
Q1 20251,951,020$196.8M4.4%−184,275−8.6%ReducedHolders
Q4 20242,135,295$190.7M3.7%−317,502−12.9%ReducedHolders
Q3 20242,452,797$205.5M3.3%−116,791−4.5%ReducedHolders
Q2 20242,569,588$197.9M3.2%−579,088−18.4%ReducedHolders
Q1 20243,148,676$215.7M3.3%−21,927−0.7%ReducedHolders
Q4 20233,170,603$183.3M2.8%+524,308+19.8%AddedHolders
Q3 20232,646,295$139.7M2.3%−15,157−0.6%ReducedHolders
Q2 20232,661,452$144.0M2.1%−778,127−22.6%ReducedHolders
Q1 20233,439,579$172.1M2.5%−463,345−11.9%ReducedHolders
Q4 20223,902,924$180.6M2.4%+98,877+2.6%AddedHolders
Q3 20223,804,047$147.3M2.1%−46,124−1.2%ReducedHolders
Q2 20223,850,171$143.5M2.0%−63,776−1.6%ReducedHolders
Q1 20223,913,947$173.3M2.0%+949,916+32.0%AddedHolders
Q4 20212,964,031$125.9M1.3%−3,096−0.1%ReducedHolders
Q3 20212,967,127$128.7M1.3%+640,340+27.5%AddedHolders
Q2 20212,326,787$99.5M1.0%00.0%UnchangedHolders
Q1 20212,326,787$89.9M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.